Yang Liu is an Oncology physician. ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
505 E Romie Ln Ste A
Salinas, CA 939014031
Telephone
831-755-1701Provider last certified this registry record 10 Mar 2026.
Clinical trials
- Effect of a Semiotically-Optimized Video Education Model on Post-Stroke Rehabilitation
Sponsor: Xiamen University
- Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases
Sponsor: Chinese PLA General Hospital
- A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer
Sponsor: Zhejiang Provincial People's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
47 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year20259 payments
- Daiichi Sankyo Inc.Program year202516 payments
- Janssen Biotech, Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
35.5%Kinase inhibitor16.4%Calquence34%Imbruvica34%Imatinib Mesylate32%Part D<11 patientsAntimetabolite8.9%Hydroxyurea100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
22.7%Serotonin-3 Receptor Antagonist9.9%Ondansetron Odt100%Part D≥22 patientsCorticosteroid7.6%Prednisone100%Part D<11 patients+ 1 more class in this area
Blood & clotting
17.1%Factor Xa inhibitor13.2%Eliquis100%Part D≥14 patientsVitamin K antagonist3.9%Warfarin Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2001–2020 per NIH RePORTER. The latest:
- Progastrin Modulates T-cell and Neutrophil Function to Modulate Colorectal Carcinoma Metastasis
University of California, San Francisco
FY2020$75,858F32CA225144 - Progastrin Modulates T-cell and Neutrophil Function to Modulate Colorectal Carcinoma Metastasis
University of California, San Francisco
FY2019$69,950F32CA225144 - The mechanism and biological significance of GRASP55 in unconventional protein secretion in cancer
University of California, San Francisco
FY2019$50,016F30CA224693
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”